
WCOE: Countering HHS’s ACA Enrollment Suppression, FDA’s Gottlieb on Expanded Access/Right to Try, “Cancer Stories No One Wants to Hear”










What Caught Our Eye: Cassidy-Graham Repeal Bill Analysis; Bipartisan Talks; Improving End-of-Life Care; Biosimilars in Cancer; and More










What Caught Our Eye 8/4: GOP Governors Look to Cut Medicaid, Young Cancer Survivors Struggle Socially, Right to Try, FDA Funding, & More










What Caught Our Eye: Advocates Raise Their Voices Over ACA Repeal; CDC Finds Disparity in Rural Cancer Deaths; Genetic Privacy; and More










What Caught Our Eye: ‘Extremely High Premiums’ for the Sick, AHCA News, FDA Aims to Control Rx Pricing, & More










What Caught Our Eye: A New GOP Health Plan, Looming Uncertainty for Insurers, Sharing Genetic Cancer Risks with Children, and More










What Caught Our Eye: Next Steps for the ACA; Gottlieb’s Confirmation; ASCO Statement on Right-to-Try; Gene Mutations in Childhood Survivors


NCCS Statement on Nomination of Dr. Scott Gottlieb for FDA Commissioner










What Caught Our Eye: High-Risk Pools, “Trumpcare,” Childhood Cancer Survivors, Medicaid Spending, Trump’s FDA Deregulation









